Fig. 2: Representative diagram illustrating the consequences of RyR2 gain-of-function or loss-of-function heterozygous mutations. | Cell Death & Disease

Fig. 2: Representative diagram illustrating the consequences of RyR2 gain-of-function or loss-of-function heterozygous mutations.

From: “Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?

Fig. 2

A During diastole, the PKA- or the CaMKII-phosphorylation of the RyR2 gain-of-function mutant channels induces a SR Ca2+ leak that increases the diastolic Ca2+ concentration and activates the NCX exchanger. This leads to ITi current which generates DADs and arrhythmias. B During AP, the ICaL activates the phosphorylated RyR2-WT channels that generate a normal calcium transient with a lower amplitude which in consequences, induces an accumulation of the residual Ca2+ in the SR which gradually increases. When the SR Ca2+ load achieves the threshold of stimulation of the phosphorylated RyR2 loss-of-function mutant channels, it releases Ca2+. This in turn activates the neighboring RyR2-WT enhancing thus the CICR mechanism. Hence, the Ca2+ release through the RyR2 loss-of-function mutant channels at the end of the Ca2+ transient induces a second phase of Ca2+ release. It activates the NCX exchanger leading to ITi current which generates EADs responsible of the pathogenesis of the CPVT syndrome.

Back to article page